\
&
Contact us
This was 1 year ago
Locationvirtual
ProgrammesThis workshop is co-organised by the OECD Global Science Forum and the European Strategy Forum for Research Infrastructures (ESFRI) and is dedicated to
Participation to the workshop is free. It is required to register. A short introduction, the full agenda and the registration link are available via the announcement of the workshop on the RICH NCP network website.
Programme in brief
10:00-10:10 Introduction (OECD and ESFRI: rationale for this workshop, workshop organisation and expectations)
10:10-11:00 Needs and expectations from decision-makers regarding the need for better data on RI-funding
11:15-11:30 Break
11:30-13:00 Current challenges in measuring public expenditures on RIs and lessons learned from existing data gathering at regional/international level
13:00-13:30 Lunch Break
13:30-15:00 Gathering public expenditures data on RIs
15:00-15:45 Possible options to standardise public expenditure on RIs data collection
15:45-16:00 Closing words and follow up
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.